Meimei Huang

Meimei Huang

Auto-generated profile, based on publicly available information

Meimei Huang

Department of Gynecology, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou 350001, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2018 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
PSPengming Sun
Pengming Sun
XMXiaodan Mao
Xiaodan Mao
MGMin Gao
Min Gao
MHMeiMei Huang
MeiMei Huang
LCLiLi Chen
LiLi Chen
JSJalid Sehouli
Jalid Sehouli
Purpose: To explore the targeted therapy of estrogen-related receptor α (ERRα) in endometrial cancer (EC) cells and its potential mechanisms. Methods: The mRNA and protein expression levels of ERRα and estrogen receptor α (ERα) were detected by qPCR and Western blotting in RL-952, AN3-CA, HEC-1A, and HEC-1B EC cell lines. After treatment with the ERRα-specific antagonist XCT790 or infection with lentivirus-mediated small interfering RNA (siRNA) targeting the ERRα (siRNA-ERRα), cell proliferation and apoptosis were evaluated by MTS assay and flow cytometry. After treatment with siRNA-ERRα, the expression profiles of transcription factors (TFs) were analyzed by protein/DNA arrays in EC cells. Results: The relative mRNA levels of ERRa in RL-952 (1±0.0831) and AN3-CA (1.162±0.0325) were significantly higher than those in HEC-1A (0.3081±0.0339) and HEC-1B (0.1119±0.0091) (P<0.05), and similar results were observed for ERRα protein levels. A higher ratio of ERa/ERRa was observed in ERα-positive RL-952 (10-fold) and ANC-3A (8.5-fold) cells, whereas a lower ratio was observed in ERα-negative HEC-1A (3.75-fold) and HEC-1B cells (0-fold). Both – exogenous XCT790 and endogenous siRNA-ERRa – can decrease the expression of ERRα, thereby inhibiting proliferation but promoting apoptosis in both ERα-positive and -negative EC cells. The XCT790 presented higher proliferation-inhibition and apoptosis rates in the ERα-positive than ERα-negative cells, whereas the siRNA-ERRα exhibited higher proliferation-inhibition and apoptosis rates in the ERα-negative than in ERα-positive cells. In total, 3 upregulated and 17 downregulated TFs were screened out by knocked-down expression of ERRα in all EC cells. Among them, the upregulated TFs organic cation transporter 3/4(Oct3/4), hepatic nuclear factor 4 (HNF4), HNF4 and chicken ovalbumin upstream TF (COUP-TF) as well as downregulated transcription factor EB (TFEB) were found to be statistically significant (P<0.05). Conclusion: Targeting ERRα provides a promising novel endocrine therapeutic strategy.

21 June 2022 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
YTYao Tong
Yao Tong
MHMeimei Huang
Meimei Huang
LCLili Chen
Lili Chen
HLHuifang Lei
Huifang Lei
HLHao Lin
Hao Lin
PSPengming Sun
Pengming Sun
We aim to investigate the correlation between the expression of estrogen-related receptor γ (ERRγ) and endometrial cancer (EC) progression and to evaluate the potential of ERRγ as a new biomarker for EC diagnosis. We analyzed the ERRγ expression profile and the correlation with the corresponding clinical characteristics of EC samples from The Cancer Genome Atlas (TCGA), the Clinical Proteomic Tumor Analysis Consortium (CPTAC) databases, and the International Cancer Genome Consortium (ICGC) databases. Immunohistochemical (IHC) analysis was conducted on tissue samples, and enzyme linked immunosorbent assay (ELISA) was used in serum samples to detect the levels of ERRγ. The diagnostic performance of ERRγ proteins was assessed using the receiver operating characteristic (ROC). ERRγ showed notably higher expression in EC tissues than in normal endometrium tissues ( ), which was consistent with the result of TCGA. Overexpression of ERRγ was significantly associated with deep myometrial invasion of EC ( ), and fasting blood glucose (FBG) was higher in EC patients with deep myometrial invasion than in those with superficial myometrial invasion ( ). Further analysis using ELISA showed that the serum ERRγ level was positively correlated with FBG (R = 0.355, ). ERRγ is overexpressed in EC and may be involved in regulating glucose metabolism and promoting myometrial invasion of EC. In addition, the area under the ROC curve (AUC) for ERRγ was 0.834, in distinguishing EC patients from healthy individuals, presented 84.0% and 80.0% sensitivity and specificity, respectively, and serum ERRγ has a good diagnostic performance in distinguishing EC patients from healthy people and may be a promising noninvasive biomarker in EC.

1 January 2021 in IOP Conference Series: Earth and Environmental Science
Verified
Conference Paper
Open access
PDF file
YWYongming Wang
Yongming Wang
YLYiran Li
Yiran Li
HLHongchi Liang
Hongchi Liang
XWXiaochun Weng
Xiaochun Weng
MHMeimei Huang
Meimei Huang
The occurrence of power grid blackout will cause major production equipment damage, cause major economic losses, or even cause casualties in some extremely serious cases. It is necessary to upgrade the technology of traditional power grid so that emergency measures can be taken when unexpected cascade failure occurs. In this work, an active power failure warning probability model is proposed for smart grid warning system. First, probabilistic evaluation of system performance is carried out to generate the historical database required by cascade state. Then, the support vector machine (SVM) algorithm is used to train the historical database, and power failure is predicted by the support vector machine (SVM) binary classifier. Finally, the proposed model is validated by IEEE 30 node system. The proposed model can well understand the essence of cascade failure and can proactively predict cascade failure, which is helpful for the planning and maintenance of power grid system.